% alzhub.org library filter
% Source: https://alzhub.org/research?category=assessment&design=trial
% 16 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{florian2023-36730056,
  author  = {Florian, H. and Wang, D. and Arnold, S. E. and Boada, M. and Guo, Q. and Jin, Z. and Zheng, H. and Fisseha, N. and others},
  title   = {{Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awad024},
  pmid    = {36730056},
  url     = {https://doi.org/10.1093/brain/awad024}
}

@article{han2017-28587629,
  author  = {Han, J. W. and Son, K. L. and Byun, H. J. and Ko, J. W. and Kim, K. and Hong, J. W. and Kim, T. H. and Kim, K. W.},
  title   = {{Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (USMART) program among patients with mild cognitive impairment: a randomized controlled crossover trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2017},
  doi     = {10.1186/s13195-017-0264-8},
  pmid    = {28587629},
  url     = {https://doi.org/10.1186/s13195-017-0264-8}
}

@article{cummings2026-41865758,
  author  = {Cummings, Jeffrey L and Atri, Alireza and Sano, Mary and Zetterberg, Henrik and Scheltens, Philip and Knop, Filip K and Johannsen, Peter and Wichmann, Christian Ahmad and others},
  title   = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials}},
  journal = {The Lancet},
  year    = {2026},
  doi     = {10.1016/s0140-6736(26)00459-9},
  pmid    = {41865758},
  url     = {https://doi.org/10.1016/s0140-6736(26)00459-9}
}

@article{burstein2014-24423155,
  author  = {Burstein, A. H. and Grimes, I. and Galasko, D. R. and Aisen, P. S. and Sabbagh, M. and Mjalli, A. M.},
  title   = {{Effect of TTP488 in patients with mild to moderate Alzheimer's disease}},
  journal = {BMC neurology},
  year    = {2014},
  doi     = {10.1186/1471-2377-14-12},
  pmid    = {24423155},
  url     = {https://doi.org/10.1186/1471-2377-14-12}
}

@article{harrington2011-21592048,
  author  = {Harrington, C. and Sawchak, S. and Chiang, C. and Davies, J. and Donovan, C. and Saunders, A. M. and Irizarry, M. and Jeter, B. and others},
  title   = {{Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies}},
  journal = {Current Alzheimer research},
  year    = {2011},
  doi     = {10.2174/156720511796391935},
  pmid    = {21592048},
  url     = {https://doi.org/10.2174/156720511796391935}
}

@article{skoog2005-16109319,
  author  = {Skoog, I. and Lithell, H. and Hansson, L. and Elmfeldt, D. and Hofman, A. and Olofsson, B. and Trenkwalder, P. and Zanchetti, A. and others},
  title   = {{Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)}},
  journal = {American journal of hypertension},
  year    = {2005},
  doi     = {10.1016/j.amjhyper.2005.02.013},
  pmid    = {16109319},
  url     = {https://doi.org/10.1016/j.amjhyper.2005.02.013}
}

@article{valentisoler2015-26388764,
  author  = {Valentí Soler, M. and Agüera-Ortiz, L. and Olazarán Rodríguez, J. and Mendoza Rebolledo, C. and Pérez Muñoz, A. and Rodríguez Pérez, I. and Osa Ruiz, E. and Barrios Sánchez, A. and others},
  title   = {{Social robots in advanced dementia}},
  journal = {Frontiers in aging neuroscience},
  year    = {2015},
  doi     = {10.3389/fnagi.2015.00133},
  pmid    = {26388764},
  url     = {https://doi.org/10.3389/fnagi.2015.00133}
}

@article{hager2007-17982894,
  author  = {Hager, K. and Kenklies, M. and McAfoose, J. and Engel, J. and Münch, G.},
  title   = {{Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis}},
  journal = {Journal of neural transmission. Supplementum},
  year    = {2007},
  doi     = {10.1007/978-3-211-73574-9_24},
  pmid    = {17982894},
  url     = {https://doi.org/10.1007/978-3-211-73574-9_24}
}

@article{maczurek2008-18655815,
  author  = {Maczurek, A. and Hager, K. and Kenklies, M. and Sharman, M. and Martins, R. and Engel, J. and Carlson, D. A. and Münch, G.},
  title   = {{Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease}},
  journal = {Advanced drug delivery reviews},
  year    = {2008},
  doi     = {10.1016/j.addr.2008.04.015},
  pmid    = {18655815},
  url     = {https://doi.org/10.1016/j.addr.2008.04.015}
}

@article{siemers2023-36641606,
  author  = {Siemers, E. and Hitchcock, J. and Sundell, K. and Dean, R. and Jerecic, J. and Cline, E. and Iverson, K. and Moore, J. and others},
  title   = {{ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2023},
  doi     = {10.14283/jpad.2022.93},
  pmid    = {36641606},
  url     = {https://doi.org/10.14283/jpad.2022.93}
}

@article{tuszynski2005-15852017,
  author  = {Tuszynski, M. H. and Thal, L. and Pay, M. and Salmon, D. P. and U, H. S. and Bakay, R. and Patel, P. and Blesch, A. and others},
  title   = {{A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease}},
  journal = {Nature medicine},
  year    = {2005},
  doi     = {10.1038/nm1239},
  pmid    = {15852017},
  url     = {https://doi.org/10.1038/nm1239}
}

@article{aarsland2003-14533126,
  author  = {Aarsland, D. and Hutchinson, M. and Larsen, J. P.},
  title   = {{Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia}},
  journal = {International journal of geriatric psychiatry},
  year    = {2003},
  doi     = {10.1002/gps.949},
  pmid    = {14533126},
  url     = {https://doi.org/10.1002/gps.949}
}

@article{edwards2007-17409748,
  author  = {Edwards, K. and Royall, D. and Hershey, L. and Lichter, D. and Hake, A. and Farlow, M. and Pasquier, F. and Johnson, S.},
  title   = {{Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2007},
  doi     = {10.1159/000101512},
  pmid    = {17409748},
  url     = {https://doi.org/10.1159/000101512}
}

@article{kaufer1996-8679057,
  author  = {Kaufer, D. I. and Cummings, J. L. and Christine, D.},
  title   = {{Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study}},
  journal = {Journal of geriatric psychiatry and neurology},
  year    = {1996},
  doi     = {10.1177/089198879600900101},
  pmid    = {8679057},
  url     = {https://doi.org/10.1177/089198879600900101}
}

@article{fick2000-10776167,
  author  = {Fick, D. and Foreman, M.},
  title   = {{Consequences of not recognizing delirium superimposed on dementia in hospitalized elderly individuals}},
  journal = {Journal of gerontological nursing},
  year    = {2000},
  doi     = {10.3928/0098-9134-20000101-09},
  pmid    = {10776167},
  url     = {https://doi.org/10.3928/0098-9134-20000101-09}
}

@article{wang2025-40911712,
  author  = {Wang, Guoqiao and Li, Yan and McDade, Eric and Xiong, Chengjie and Hartz, Sarah M. and Bateman, Randall John and Morris, John C. and Schneider, Lon S. S. and others},
  title   = {{Clinical progression on CDR‐SB©: Progression‐free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70643},
  pmid    = {40911712},
  url     = {https://doi.org/10.1002/alz.70643}
}